October 11, 2016 / 1:26 PM / 9 months ago

BRIEF-Exicure announces positive Phase 1 data for topical Anti-TNF compound AST-005

1 Min Read

Oct 11 (Reuters) - Exicure Inc:

* Press release - Exicure announces positive phase 1 data for topical anti-TNF compound AST-005 in patients with mild to moderate Psoriasis Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below